Harmony Biosciences Holdings (HRMY) Change in Account Payables (2019 - 2026)

Harmony Biosciences Holdings has disclosed Change in Account Payables across 8 years of filings, most recently posting $10.9 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at $10.9 million, up 193.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.1 million (up 1114.94% YoY), and the FY2025 annual result was $3.9 million, up 173.35% from the prior year.
• Change in Account Payables came in at $10.9 million for Q1 2026 at Harmony Biosciences Holdings, up from -$8.6 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $10.9 million in Q1 2026 to a low of -$12.2 million in Q3 2024.
• The 5-year median for Change in Account Payables is $2.6 million (2023), against an average of $1.2 million.
• Peak annual rise in Change in Account Payables reached 4021.48% in 2024, while the deepest fall reached 50529.17% in 2024.
• Harmony Biosciences Holdings' Change in Account Payables stood at -$6.3 million in 2022, then jumped by 198.93% to $6.2 million in 2023, then slumped by 48.16% to $3.2 million in 2024, then sank by 369.24% to -$8.6 million in 2025, then jumped by 226.12% to $10.9 million in 2026.
• The last three Change in Account Payables figures came in at $10.9 million (Q1 2026), -$8.6 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.